SKI Market

A+| A| A-|

Indian Indices

Sensex

75,867.80 -141.90
( -0.19%)

Global Indices

Nasdaq

50,493.86 -106.84
(-0.21%)

Dow Jones

7,540.47 46.00
(0.61%)

Hang Seng

65,194.32 198.23
(0.30%)

Nikkei 225

10,507.74 16.35
(0.16%)

Forex

USD-INR

95.26 -0.35
(-0.37%)

EUR-INR

110.89 -0.08
(-0.07%)

GBP-INR

128.53 0.11
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

531752

INE703D01023

0.9409956

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

37.91

EPS(TTM)

Face Value()

Div & Yield %

0.01

Back

Vedavaag Systems consolidated net profit declines 55.47% in the September 2025 quarter

Nov 17,2025

Net profit of Vedavaag Systems declined 55.47% to Rs 1.22 crore in the quarter ended September 2025 as against Rs 2.74 crore during the previous quarter ended September 2024. Sales declined 13.66% to Rs 21.62 crore in the quarter ended September 2025 as against Rs 25.04 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	21.62	25.04	-14
OPM %	13.74	17.25	-
PBDT	2.74	4.20	-35
PBT	1.78	3.67	-51
NP	1.22	2.74	-55

75,867.80 -141.90 ( -0.19%)

50,493.86 -106.84 (-0.21%)

7,540.47 46.00 (0.61%)

65,194.32 198.23 (0.30%)

10,507.74 16.35 (0.16%)

95.26 -0.35 (-0.37%)

110.89 -0.08 (-0.07%)

128.53 0.11 (0.08%)

0.60 0.00 (-0.21%)